BusinessOtonomy Successfully Completes Open-Label Clinical Trial for OTIPRIO® in Patients with History of Otitis Media Requiring Tympanostomy TubesBy Nasdaq OMXSep 15, 2016, 11:30 AM UTC
BusinessOtonomy Announces OTIPRIO® Data Presentation and Symposium at American Academy of Otolaryngology - Head and Neck Surgery Foundation Annual MeetingBy Nasdaq OMXSep 13, 2016, 11:30 AM UTC
BusinessOtonomy to Present at Baird Global Healthcare ConferenceBy Nasdaq OMXSep 1, 2016, 11:30 AM UTC
BusinessOtonomy Announces Phase 3 Clinical Trial Plan for OTIPRIO™ in Otitis Externa Patients Based on Successful End-of-Phase 2 Review by FDABy Nasdaq OMXApr 18, 2016, 11:30 AM UTC
BusinessOtonomy Initiates Patient Enrollment in Second Phase 3 Clinical Trial of OTO-104 in Ménière’s DiseaseBy Nasdaq OMXMar 23, 2016, 11:30 AM UTC
BusinessOtonomy Announces Publication of OTIPRIO™ Phase 3 Clinical Trial Results in JAMA OtolaryngologyBy Nasdaq OMXMar 18, 2016, 11:30 AM UTC
BusinessOtonomy Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate UpdateBy Nasdaq OMXMar 7, 2016, 9:14 PM UTC
BusinessOtonomy Initiates Phase 2 Clinical Trial of OTIPRIO™ in Pediatric Patients With Acute Otitis Media With Tympanostomy TubesBy Nasdaq OMXMar 3, 2016, 12:30 PM UTC
